Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

389 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Gastrointestinal innovations].
Malfertheiner P, Mayerle J. Malfertheiner P, et al. Among authors: mayerle j. MMW Fortschr Med. 2018 Nov;160(Suppl 3):58-63. doi: 10.1007/s15006-018-1124-6. MMW Fortschr Med. 2018. PMID: 30421194 Review. German. No abstract available.
Predictors of ribociclib-mediated antitumour effects in native and sorafenib-resistant human hepatocellular carcinoma cells.
Reiter FP, Denk G, Ziesch A, Ofner A, Wimmer R, Hohenester S, Schiergens TS, Spampatti M, Ye L, Itzel T, Munker S, Teufel A, Gerbes AL, Mayerle J, De Toni EN. Reiter FP, et al. Among authors: mayerle j. Cell Oncol (Dordr). 2019 Oct;42(5):705-715. doi: 10.1007/s13402-019-00458-8. Epub 2019 Jun 27. Cell Oncol (Dordr). 2019. PMID: 31250364
Circulating DNA as prognostic biomarker in patients with advanced hepatocellular carcinoma: a translational exploratory study from the SORAMIC trial.
Alunni-Fabbroni M, Rönsch K, Huber T, Cyran CC, Seidensticker M, Mayerle J, Pech M, Basu B, Verslype C, Benckert J, Malfertheiner P, Ricke J. Alunni-Fabbroni M, et al. Among authors: mayerle j. J Transl Med. 2019 Oct 1;17(1):328. doi: 10.1186/s12967-019-2079-9. J Transl Med. 2019. PMID: 31570105 Free PMC article. Clinical Trial.
The value of sorafenib trough levels in patients with advanced hepatocellular carcinoma - a substudy of the SORAMIC trial.
Labeur TA, Hofsink Q, Takkenberg RB, van Delden OM, Mathôt RAA, Schinner R, Malfertheiner P, Amthauer H, Schütte K, Basu B, Kuhl C, Mayerle J, Ricke J, Klümpen HJ. Labeur TA, et al. Among authors: mayerle j. Acta Oncol. 2020 Sep;59(9):1028-1035. doi: 10.1080/0284186X.2020.1759826. Epub 2020 May 5. Acta Oncol. 2020. PMID: 32366155 Clinical Trial.
389 results